| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |